Drugs / HF0220
last change Aug 2008 re-read 3 minutes ago

HF0220

Developed for
Alzheimer disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT00357357 Comparator Jul 2006 → Aug 2008 Alzheimer disease Hunter-Fleming Ltd Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HF0220 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00357357 ↗